Evaluation of the use of combined extracorporeal detoxification in patients with severe acute pancreatitis: a retrospective cohort study
Authors:
- S. V. MasolitinSMS. V. Masolitin
- Denis N. ProtsenkoDPDenis N. Protsenko
- I. N. TyurinITI. N. Tyurin
- T. G. KimTKT. G. Kim
- M. A. MagomedovMMM. A. Magomedov
- L. A. GrishinaLGL. A. Grishina
- Е. Б. ГельфандЕГЕ. Б. Гельфанд
- O. V. IgnatenkoOIO. V. Ignatenko
- A. O. BykovABA. O. Bykov
- E. Y. KalininEKE. Y. Kalinin
- A. V. YaralyanAYA. V. Yaralyan
Open Access
- 28 July 2023
- journal article
- research article
- Published by Practical Medicine Publishing House in Annals of Critical Care
- No. 3,p. 108-121
Abstract
INTRODUCTION: Morbidity and mortality of severe acute pancreatitis (SAP) remains high. The most important direction of therapy is the relief of endotoxicosis. The use of extracorporeal detoxification (ECD) is a debatable problem. OBJECTIVE: Improving the results of treatment of patients with SAP, through the use of ECD methods. MATERIALS AND METHODS: The study included 25 patients. Group 1: ECD included 9 patients who used standard therapy with selective hemoperfusion (HP) and continuous veno-venous hemofiltration (CVVHF). Group 2 (control) 16 patients received standard therapy. We performed a comparative analysis of the main clinical and laboratory parameters and treatment outcomes between the groups. RESULTS: The use of ECD allowed to reduce the number of leukocytes from 14.9 to 8.6 × 109/l by 5 days of therapy in group 1, and from 17.6 to 16.1 × 109/l in group 2, respectively. The dynamics of CRP concentration from 1 to 5 days changed from 315.6 to 184.6 mg/ml and 274.2 to 352.9 mg/ml in groups 1 and 2, respectively. The level of PCT concentration on days 1–5 decreased from 4.5 to 2.1 ng/ml and 3.95 to 6.9 ng/ml in groups 1 and 2, respectively. The concentration of IL-6 decreased from 1624.3 to 914.3 pg/ml in group 1, and increased from 1529.8 to 1861.8 pg/ml in group 2, respectively. The dynamics of pH in group 1 was from 7.14 to 7.4 by the 5th day of therapy and 7.13 to 7.22 in group 2, respectively. SOFA by day 5 in group 1 was 4 points and 11 points in group 2, respectively. CONCLUSIONS: The use of HP and CVVHF in complex intensive care is accompanied by a significant regression of markers of endogenous intoxication, resolution of the acid-base state and reduces the severity of organ dysfunction and the risk of adverse outcomes, compared with standard treatment.Keywords
This publication has 41 references indexed in Scilit:
- An Official ATS/AACN/ACCP/ESICM/SCCM Policy Statement: Responding to Requests for Potentially Inappropriate Treatments in Intensive Care UnitsAmerican Journal of Respiratory and Critical Care Medicine, 2015
- Early Factors Associated With Fluid Sequestration and Outcomes of Patients With Acute PancreatitisClinical Gastroenterology and Hepatology, 2014
- Online haemodiafiltration: definition, dose quantification and safety revisitedNephrology Dialysis Transplantation, 2013
- Classification of acute pancreatitis—2012: revision of the Atlanta classification and definitions by international consensusGut, 2012
- Acute Pancreatitis: Bench to the BedsideGastroenterology, 2007
- Blood and Plasma Treatments: The Rationale of High-Volume Hemofiltration2007
- A Case of Severe Acute Pancreatitis Treated With CTR‐001 Direct Hemoperfusion for Cytokine ApheresisTherapeutic Apheresis and Dialysis, 2005
- Acute Pancreatitis: Assessment of Severity with Clinical and CT EvaluationRadiology, 2002
- Relationship between NF-κB and Trypsinogen Activation in Rat Pancreas after Supramaximal Caerulein StimulationBiochemical and Biophysical Research Communications, 2001
- Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trialThe Lancet, 2000